Physician profile
Yanjun Wang
NPI 1033640800
$1,472.82
in general payments reported to CMS, 2019-2025
9 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.99 · 2023: $452 · 2024: $404 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,372.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $353.37 | 2023-2025 | Mounjaro, Kisunla |
| Otsuka America Pharmaceutical, INC. | $249.70 | 2023-2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $150.00 | 2025 | |
| Viiv Healthcare Company | $124.99 | 2025 | Apretude |
| Exact Sciences Corporation | $124.98 | 2024 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $124.83 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $123.14 | 2023 | Dupixent |
| Glaxosmithkline, LLC. | $121.82 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $99.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yanjun Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.